Immunome IMNM Business Segments — General And Administrative Expense

Similar metrics at other companies

VERXSingle Reportable — General And Administrative Expense

$54.34M+20.7%

IOVASingle Reportable — General And Administrative Expense

$18.7M-5.8%

ACLSSingle Reportable — General And Administrative Expense

$26.76M+54.2%

ALMSSingle Reportable — General And Administrative Expense

$18.61M-16.5%

CAPRSingle Reportable — General And Administrative Expense

$9.4M+54.9%

MMSISingle Reportable — General And Administrative Expense

$44.25M+4.0%

Questions, answered.

What is Immunome's business segments — general and administrative expense?

Immunome (IMNM) reported business segments — general and administrative expense of -$8.65M in Q1 2026.

How has Immunome's business segments — general and administrative expense changed year-over-year?

Immunome's business segments — general and administrative expense decreased by 17.3% year-over-year, from -$7.38M to -$8.65M.

What is the long-term trend for Immunome's business segments — general and administrative expense?

Over 2 years (2023 to 2025), Immunome's business segments — general and administrative expense has grown at a 63.4% compound annual growth rate (CAGR), from $19.66M to $52.46M.

What does business segments — general and administrative expense mean?

Covers the costs of supporting the business functions, including executive management, legal, finance, human resources, and other corporate overheads. This metric reflects the operational efficiency of the company's management structure and its ability to scale administrative support relative to its growth. High levels relative to revenue may indicate a need for improved operational leverage.